(Q33642308)

English

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

based on heuristic

inferred from title

immunosuppression

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Lode J Swinnen

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Michael LeBlanc

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Thomas M Grogan

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Patrick J Stiff

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Alan M Miller

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Yvette Kasamon

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Thomas P Miller

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Richard I Fisher

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Transplantation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

86

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

215-222

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

28 July 2018

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

28 July 2018

Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

28 July 2018

The diagnosis and treatment of posttransplant lymphoproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

28 July 2018

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

28 July 2018

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

30 October 2018

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

30 October 2018

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

30 October 2018

Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

30 October 2018

Clinical characteristics of post-transplant lymphoproliferative disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

30 October 2018

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029101

30 October 2018

Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18645482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18645482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18645482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

https://pubmed.ncbi.nlm.nih.gov/18645482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive treatment for postcardiac transplant lymphoproliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18645482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/TP.0B013E3181761659

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18645482%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33642308&oldid=1979207545"